Lv3
318 积分 2021-04-15 加入
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
15小时前
待确认
Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline, Version 2026.1.0
16天前
已完结
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
17天前
已完结
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
1个月前
已完结
Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers
1个月前
已完结
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
1个月前
已完结
Metformin repurposing in gout: enhancing febuxostat efficacy through anti-inflammatory and metabolic modulation: a randomized controlled double-blind study
1个月前
已完结
Efficacy of neo-adjuvant chemotherapy with TEC regimen on breast cancer
1个月前
已完结
Pyridoimidazolyl Sulfonamide Compound 2 : A Superior Dual-Acting Drug Candidate with Potent URAT1 Inhibition and Anti-Inflammatory Activity for Gout Management
1个月前
已完结
Early versus deferred immunotherapy in urothelial carcinoma: a review of evidence and post-progression survival
2个月前
已完结
皖公网安备34019202002308
